摘要
目的探讨HBV DNA复制水平与HBV YMDD突变的相关性。方法运用实时荧光定量PCR核酸检测技术,检测150例慢性乙型肝炎(CHB)患者未服用拉米夫定治疗前血清HBV DNA水平以及服用拉米夫定治疗12个月血清中YMDD突变情况。结果治疗前患者血清HBV DNA载量较低者YMDD突变率较低,治疗前病毒载量较高者YMDD突变率也较高(P<0.05)。结论 HBVYMDD突变与治疗前HBV DNA水平呈正相关,治疗前患者血清HBV DNA定量水平检测可作为发生YMDD突变的早期观察指标之一。
学科与关键词
关键词
肝炎,乙型,慢性拉米夫定DNA,病毒变异(遗传学)
- Correlation of the occurrence of YMDD mutations with HBV genotypes,HBV-DNA levels,and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatmentFeng Wu; Min Jin Wu; Xiao Lin Zhuge; Shao Ming Zhu; Biao Zhu Department of Chinese Pharmacy; Department of Laboratory Medicine; State Key Laboratory for Diagnosis; Treatment of Infectious Diseases; First Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou; ChinaHEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, (02): 172-176.
- 356例乙型肝炎患者病毒分型及拉米夫定治疗所致耐药突变株变化分析李延武; 李卓成实用临床医药杂志, 2013, (13): 27-29.
- 下一代测序法检测乙型肝炎病毒YMDD突变的方法学建立及性能评价余学高; 邓间开; 陈耀铭; 陈培松; 何小洪; 钟良英; 黄彬分子诊断与治疗杂志, 2019, (06): 446-450+484.
